Cancer modeling meets human organoid technology
- PMID: 31171691
- DOI: 10.1126/science.aaw6985
Cancer modeling meets human organoid technology
Abstract
Organoids are microscopic self-organizing, three-dimensional structures that are grown from stem cells in vitro. They recapitulate many structural and functional aspects of their in vivo counterpart organs. This versatile technology has led to the development of many novel human cancer models. It is now possible to create indefinitely expanding organoids starting from tumor tissue of individuals suffering from a range of carcinomas. Alternatively, CRISPR-based gene modification allows the engineering of organoid models of cancer through the introduction of any combination of cancer gene alterations to normal organoids. When combined with immune cells and fibroblasts, tumor organoids become models for the cancer microenvironment enabling immune-oncology applications. Emerging evidence indicates that organoids can be used to accurately predict drug responses in a personalized treatment setting. Here, we review the current state and future prospects of the rapidly evolving tumor organoid field.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Similar articles
-
Organoids: approaches and utility in cancer research.Chin Med J (Engl). 2023 Aug 5;136(15):1783-1793. doi: 10.1097/CM9.0000000000002477. Chin Med J (Engl). 2023. PMID: 37365679 Free PMC article.
-
Organoids: An intermediate modeling platform in precision oncology.Cancer Lett. 2018 Feb 1;414:174-180. doi: 10.1016/j.canlet.2017.11.021. Epub 2017 Nov 22. Cancer Lett. 2018. PMID: 29174804 Review.
-
Organoid technology and applications in cancer research.J Hematol Oncol. 2018 Sep 15;11(1):116. doi: 10.1186/s13045-018-0662-9. J Hematol Oncol. 2018. PMID: 30219074 Free PMC article. Review.
-
Primate Organoids and Gene-Editing Technologies toward Next-Generation Biomedical Research.Trends Biotechnol. 2021 Dec;39(12):1332-1342. doi: 10.1016/j.tibtech.2021.03.010. Epub 2021 Apr 30. Trends Biotechnol. 2021. PMID: 33941418 Review.
-
Cancer organoid co-culture model system: Novel approach to guide precision medicine.Front Immunol. 2023 Jan 12;13:1061388. doi: 10.3389/fimmu.2022.1061388. eCollection 2022. Front Immunol. 2023. PMID: 36713421 Free PMC article. Review.
Cited by
-
Modeling epithelial-mesenchymal transition in patient-derived breast cancer organoids.Front Oncol. 2024 Oct 14;14:1470379. doi: 10.3389/fonc.2024.1470379. eCollection 2024. Front Oncol. 2024. PMID: 39469640 Free PMC article.
-
Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells.Theranostics. 2020 May 25;10(15):6928-6945. doi: 10.7150/thno.43811. eCollection 2020. Theranostics. 2020. PMID: 32550913 Free PMC article.
-
Harnessing metabolic dependencies in pancreatic cancers.Nat Rev Gastroenterol Hepatol. 2021 Jul;18(7):482-492. doi: 10.1038/s41575-021-00431-7. Epub 2021 Mar 19. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33742165 Free PMC article. Review.
-
Single Cell RNA Sequencing: A New Frontier in Pancreatic Ductal Adenocarcinoma.Cancers (Basel). 2022 Sep 22;14(19):4589. doi: 10.3390/cancers14194589. Cancers (Basel). 2022. PMID: 36230515 Free PMC article. Review.
-
Three-Dimensional Printed Stamps for the Fabrication of Patterned Microwells and High-Throughput Production of Homogeneous Cell Spheroids.3D Print Addit Manuf. 2020 Jun 1;7(3):139-147. doi: 10.1089/3dp.2019.0129. Epub 2020 Jun 5. 3D Print Addit Manuf. 2020. PMID: 32855996 Free PMC article.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources